Llorens Pharmaceutical International Division
13 drugs in NADAC|13 Generic,0 Brand
Llorens Pharmaceutical International Division lists 13 NDCs in the CMS NADAC file (13 generic, 0 brand), at an average NADAC of $0.10 per unit, with a week-over-week move of -1.1% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
13
13G / 0B
Avg Price / Unit
$0.0976
$0.01 – $0.28
Avg 7d Change
-1.14%
Across 7 drugs with changes
7d Activity
of 13 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
Acetaminophen, Dexbrompheniramine Maleate market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Expectorant therapeutic class
Review the broader class where Llorens Pharmaceutical International Division has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Llorens Pharmaceutical International Division make?
Llorens Pharmaceutical International Division lists 13 NDCs in the CMS NADAC file — 13 generic and 0 brand products.
What is the average price of Llorens Pharmaceutical International Division drugs?
The average NADAC across Llorens Pharmaceutical International Division's portfolio is $0.0976 per unit, ranging from $0.0069 to $0.2752.
What types of drugs does Llorens Pharmaceutical International Division make?
Llorens Pharmaceutical International Division makes drugs across 7 FDA pharmacologic classes. The most common by NDC count are Expectorant (6), Sigma-1 Agonist (4), Uncompetitive N-methyl-D-aspartate Receptor Antagonist (4), alpha-1 Adrenergic Agonist (2), Opioid Agonist (1).
Has Llorens Pharmaceutical International Division had any drug recalls?
No FDA enforcement recalls are matched to Llorens Pharmaceutical International Division in the openFDA feed.
How has Llorens Pharmaceutical International Division's pricing changed recently?
Over the past 7 days, 1 Llorens Pharmaceutical International Division product rose and 6 fell, with a portfolio-wide average change of -1.1%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TUSNEL-DM PED 2.5-25-1.25 MG/ML Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl | $0.2752 per ML | -3.31% |
DOLOGESIC 500-1 MG CAPLET Acetaminophen, Dexbrompheniramine Maleate | $0.2152 per EA | — |
DOLOGESIC-DF 500-1 MG CAPLET Acetaminophen, Dexbrompheniramine Maleate | $0.2152 per EA | — |
DOLOGESIC 500-1 MG CAPLET Acetaminophen, Dexbrompheniramine Maleate | $0.2152 per EA | — |
TUSNEL C SYRUP Codeine Phosphate, Guiafenesin, Pseudoephedrine HCl | $0.1944 per ML | — |
SENNA 8.8 MG/5 ML SYRUP Sennosides | $0.0369 per ML | -1.62% |
TUSNEL DM PEDIATRIC LIQUID Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl | $0.0276 per ML | — |
TUSNEL-EX 100 MG/5 ML LIQUID Guaifenesin | $0.0229 per ML | +0.04% |
DOCUSATE SODIUM 50 MG/5 ML LIQ Docusate Sodium | $0.0201 per ML | -1.76% |
ALLERGY RELIEF 12.5 MG/5 ML Diphenhydramine HCl | $0.0174 per ML | -0.40% |
TUSNEL DIABETIC LIQUID Dextromethorphan, Guaifenesin | $0.0111 per ML | -0.09% |
ACETAMINOPHEN 160 MG/5 ML LIQ Acetaminophen | $0.0107 per ML | -0.84% |
TUSNEL DIABETIC LIQUID Dextromethorphan, Guaifenesin | $0.0069 per ML | — |